Decision aid reduces conflict in breast cancer treatment

Decision aid reduces conflict in breast cancer treatment
Chinese women considering surgery for breast cancer have less decisional conflict and subsequent regret if they receive an educational take-home booklet to involve them in decision making, according to a study published online July 8 in the Journal of Clinical Oncology.

(HealthDay)—Chinese women considering surgery for breast cancer have less decisional conflict and subsequent regret if they receive an educational take-home booklet to involve them in decision making, according to a study published online July 8 in the Journal of Clinical Oncology.

Noting that breast cancer decision aid studies have been done in Western women for primary surgery, Wendy W.T. Lam, Ph.D., from the University of Hong Kong, and colleagues randomly assigned 276 Chinese women considering surgery for early-stage to a take-home booklet (decision aid) or the standard information booklet (control) after the initial consultation.

Based on interview-based questionnaires, the researchers found that decisional conflict scores were significantly lower for the decision-aid group one week after consultation. The decision-aid group also had significantly lower decision regret scores four and 10 months after surgery and significantly lower depression scores 10 months after surgery.

"Use of this decision aid was associated with reductions in decisional conflict, decision regret, and depression over time without increasing among Chinese women," Lam and colleagues write.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Young breast cancer patients often opt for mastectomy

May 30, 2013

A new study of young women with breast cancer has found that most chose to have a mastectomy rather than a surgical procedure that would conserve the breast, researchers will report at the 49th Annual Meeting of the American ...

Recommended for you

How a common antacid could lead to cheaper anti-cancer drugs

5 hours ago

A popular indigestion medication can increase survival in colorectal cancer, according to research published in ecancermedicalscience. But in fact, scientists have studied this for years - and a group of cancer advocates want t ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.